Richard Pops serves as Alkermes’ Chairman and Chief Executive Officer. He joined Alkermes as CEO in 1991 and under his leadership, the organization has grown from a privately held company with 25 employees to an international, publicly-traded biopharmaceutical company with approximately 2,000 employees.
Mr. Pops currently serves as Chairman of the Board of Directors of the Midsized Biotech Alliance of America (the MBAA) and on the Boards of Directors of Neurocrine Biosciences, the Biotechnology Industry Organization (BIO) and the Pharmaceutical Research and Manufacturers of America (PhRMA).